Genestra HMF Multi Strain 50, 30 Vegi-Caps

Description

HMF Multi Strain 50 capsules include 50 billion CFU from a combination of 15 probiotic strains. These research-driven strains were selected based on their ability to support both gastrointestinal and immune health. HMF Multi Strain 50’s probiotic consortium contains proprietary human-sourced strains, and includes 8 strains of Lactobacilli and 6 strains of Bifidobacteria. Saccharomyces cerevisiae subsp. boulardii (CNCM-I-1079) live yeast cells are also provided for additional microflora support.
In a recent placebo-controlled clinical trial, daily supplementation with HN019 for two weeks significantly reduced intestinal transit time; following supplementation, intestinal transit time was decreased by approximately 30%, which was associated with an approximate 35.8% reduction in occasional constipation. BL-04 and NCFM™ support year-round immune health and may enhance certain aspects of cellular immunity, such as cytokine-dependent cellular signaling.  Two recent, placebo-controlled human clinical trials have found that these strains provide support for seasonal immune health in healthy participants. As well, supplementation with a combination of CUL-60, CUL-21, CUL-31 and CUL-20 may help to enhance certain aspects of cellular immunity in healthy individuals.*

MEDICINAL INGREDIENTS – EACH CAPSULE CONTAINS:
Probiotic Consortium/ Consortium probiotique. . . . 50 billion CFU/ milliards d’UFC
Lactobacillus acidophilus (CUL-60 & CUL-21). . . . . . . . 20 billion CFU/ milliards d’UFC
Bifidobacterium animalis subsp. lactis (HN019). . . . . . 5 billion CFU/ milliards d’UFC
Bifidobacterium animalis subsp. lactis (CUL-34)
& Bifidobacterium bifidum (CUL-20). . . . . . . . . . . . . . . 5 billion CFU/ milliards d’UFC
Bifidobacterium animalis subsp. lactis (BL-04). . . . 3.75 billion CFU/ milliards d’UFC
Lactobacillus salivarius (CUL-61). . . . . . . . . . . . . . . . . . . 3 billion CFU/ milliards d’UFC
Lactobacillus gasseri (CUL-09). . . . . . . . . . . . . . . . . . . . . 2 billion CFU/ milliards d’UFC
Bifidobacterium breve (CUL-74). . . . . . . . . . . . . . . . . . . . 2 billion CFU/ milliards d’UFC
Lactobacillus casei (CUL-06). . . . . . . . . . . . . . . . . . . . . . 2 billion CFU/ milliards d’UFC
Lactobacillus paracasei (CUL-08). . . . . . . . . . . . . . . . . . 2 billion CFU/ milliards d’UFC
Lactobacillus plantarum (CUL-66). . . . . . . . . . . . . . . . . . 2 billion CFU/ milliards d’UFC
Bifidobacterium animalis subsp. lactis (CUL-62). . . . 1.5 billion CFU/ milliards d’UFC
Lactobacillus acidophilus (NCFM/MD). . . . . . . . . . . . 1.25 billion CFU/ milliards d’UFC
Saccharomyces cerevisiae
subsp. boulardii (CNCM-I-1079). . . . . . . . . . . . . . . . . 0.5 billion CFU/ milliards d’UFC

NON-MEDICINAL INGREDIENTS:
Hypromellose, cellulose, sunflower lecithin, silica. Ingredients used to maintain viability of probiotics (dipotassium phosphate, monopotassium phosphate, trehalose, sucrose, sodium chloride, sodium ascorbate, maltodextrin).

RECOMMENDED DOSE – ADULTS, ADOLESCENTS & CHILDREN ( 6 YEARS & OLDER):
 Take 1 capsule daily, at least 2 to 3 hours before or after taking antibiotics or antifungals, or as recommended by your healthcare practitioner.

RISK INFORMATION:
Do not use this product if you have an immune-compromised condition or are taking tetracycline. Consult your healthcare practitioner prior to use if you have fever, vomiting, bloody diarrhoea or severe abdominal pain. Stop use and consult your healthcare practitioner if symptoms of digestive upset occur, worsen or persist beyond 3 days. Keep out of the reach of children. Use only if safety seal is intact. Store under refrigeration (below 8 °C).